Details for New Drug Application (NDA): 209439
✉ Email this page to a colleague
The generic ingredient in BLEOMYCIN SULFATE is bleomycin sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.
Summary for 209439
Tradename: | BLEOMYCIN SULFATE |
Applicant: | Cipla |
Ingredient: | bleomycin sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 209439
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 209439 | ANDA | Cipla USA Inc. | 69097-364 | 69097-364-36 | 1 VIAL in 1 CARTON (69097-364-36) / 1 INJECTION in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 15 UNITS BASE/VIAL | ||||
Approval Date: | Mar 11, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription